A 60 MeV proton beam-line dedicated to research and development programs.

Beam-line Cyclotron FLASH radiotherapy Instrumentation testing Proton irradiation Radiation hardness testing

Journal

Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine
ISSN: 1872-9800
Titre abrégé: Appl Radiat Isot
Pays: England
ID NLM: 9306253

Informations de publication

Date de publication:
Jun 2022
Historique:
received: 10 12 2021
revised: 09 02 2022
accepted: 04 03 2022
pubmed: 19 3 2022
medline: 14 4 2022
entrez: 18 3 2022
Statut: ppublish

Résumé

A new proton beam-line dedicated to R&D programs has been developed at CentreAntoine Lacassagne (CAL), in Nice (France), in collaboration with the Centrenational d'études spatiales (CNES). This is the second beam-line of the MEDICYC 65 MeV cyclotron that is currently in operation, the first being the clinical 'eye-line' used for ocular proton therapy. The R&D beam-line is proposed with two configurations, the first producing a Gaussian narrow beam of a few mm width, the second a 100 mm diameter flat beam with a homogeneity better than ±3%. The energy range is (20 - ∼60) MeV, where the exact upper limit depends on the beam configuration being used. The energy spread of the non-degraded beam is (0.3 ± 0.1) MeV. A beam current between 10 pA and 10 μA can be produced with a stability better than 0.2% above 100 pA, and 2% below. The beam can be monitored online at a precision better than 5% in the flux range 1E5 (1E6) - 1E9 (1E10) p/cm

Identifiants

pubmed: 35303628
pii: S0969-8043(22)00089-6
doi: 10.1016/j.apradiso.2022.110190
pii:
doi:

Substances chimiques

Protons 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

110190

Informations de copyright

Copyright © 2022 Elsevier Ltd. All rights reserved.

Auteurs

P Hofverberg (P)

Centre Antoine Lacassagne, Nice, France. Electronic address: johan-petter.hofverberg@nice.unicancer.fr.

M Antunes (M)

Centre Antoine Lacassagne, Nice, France.

C Armando (C)

Centre Antoine Lacassagne, Nice, France.

J-M Bergerot (JM)

Centre Antoine Lacassagne, Nice, France.

E Bourrel (E)

Centre Antoine Lacassagne, Nice, France.

J-F Dicarlo (JF)

Centre Antoine Lacassagne, Nice, France.

G Donadey (G)

Centre Antoine Lacassagne, Nice, France.

S Dumas (S)

Centre Antoine Lacassagne, Nice, France.

D Fayaud (D)

Centre Antoine Lacassagne, Nice, France.

J-C Grini (JC)

Centre Antoine Lacassagne, Nice, France.

A Giusto (A)

Centre Antoine Lacassagne, Nice, France.

Y Payan (Y)

Centre Antoine Lacassagne, Nice, France.

M Rolion (M)

Centre Antoine Lacassagne, Nice, France.

C Salicis (C)

Centre Antoine Lacassagne, Nice, France.

G Angellier (G)

Centre Antoine Lacassagne, Nice, France.

J Hérault (J)

Centre Antoine Lacassagne, Nice, France.

D Maneval (D)

Centre Antoine Lacassagne, Nice, France.

M Vidal (M)

Centre Antoine Lacassagne, Nice, France.

P Mandrillon (P)

AIMA Developpement, Nice, France.

F Bezerra (F)

CNES, Toulouse, France.

J Mekki (J)

CNES, Toulouse, France.

R Trimaud (R)

Centre Antoine Lacassagne, Nice, France.

Articles similaires

Humans Lung Diseases Chronic Disease Research Pulmonary Disease, Chronic Obstructive
Humans Students Universities Hispanic or Latino Mentors
Humans Female Precision Medicine Radiotherapy Planning, Computer-Assisted Breast Neoplasms
Adult Aged Female Humans Male

Classifications MeSH